Endogena Therapeutics
Phase 1/2Endogena Therapeutics’ approach for endogenous regenerative medicine will result in a novel treatment paradigm for common degenerative diseases that are becoming more prevalent due to demographic changes.
Founded
2013
Focus
OphthalmologyRegenerative Medicine
About
Endogena Therapeutics’ approach for endogenous regenerative medicine will result in a novel treatment paradigm for common degenerative diseases that are becoming more prevalent due to demographic changes.
Company Info
TypePrivate
Founded2013
LocationBasel, Switzerland
StagePhase 1/2
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile